L3VLUP
ProSign in

BMY in the 13F filings

Bristol-myers Squibb Co · CUSIP 110122108

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Mar 2025
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 12 May 2025
Managers listing it
20
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q4 2024 and Q1 2025; 18 listed it in both
Shares listed
108,601,856
combined, among listed positions
Reported value
$6.6bn
combined, at the quarter end

Among the 95 comparable managers: 9 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing BMY in Q1 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

20 of 20 holders

ActionFiling
Wellington Management Group LLP23,728,443$1.4bn0.28%Added+17,750,93813 May 2025 (the filing on sec.gov)
Fidelity (FMR LLC)21,621,426$1.3bn0.08%Trimmed-9,489,3935 Nov 2026 (the filing on sec.gov)
Invesco Ltd17,463,156$1.1bn0.20%Added+1,025,76612 May 2025 (the filing on sec.gov)
Dodge & Cox13,030,562$795m0.45%Trimmed-2,371,90614 May 2025 (the filing on sec.gov)
AQR Capital Management LLC5,969,030$364m0.38%Added+1,962,23315 May 2025 (the filing on sec.gov)
T. Rowe Price Associates Inc5,789,376$353munder 0.1%Trimmed-1,738,53514 May 2025 (the filing on sec.gov)
Neuberger Berman Group LLC4,517,754$275m0.23%Added+1,866,88227 Oct 2026 (the filing on sec.gov)
AllianceBernstein LP3,308,554$202m0.07%Trimmed-215,85215 May 2025 (the filing on sec.gov)
Bridgewater Associates LP2,341,238$143m0.66%Added+280,16214 May 2025 (the filing on sec.gov)
Arrowstreet Capital LP2,140,183$131m0.11%Addedn.a.14 May 2025 (the filing on sec.gov)
Renaissance Technologies LLC2,074,133$127m0.19%Added+1,013,60014 May 2025 (the filing on sec.gov)
Man Group PLC1,962,454$120m0.30%Added+234,32715 May 2025 (the filing on sec.gov)
Woodline Partners LP1,291,615$79m0.51%Trimmed-270,00715 May 2025 (the filing on sec.gov)
Janus Henderson Group Ltd1,182,599$71munder 0.1%Trimmed-1,192,99415 May 2025 (the filing on sec.gov)
Capital Research Global Investors1,150,000$70munder 0.1%Held012 May 2025 (the filing on sec.gov)
Two Sigma Advisers LP738,500$45m0.10%Trimmed-1,119,40015 May 2025 (the filing on sec.gov)
Acadian Asset Management LLC167,694$10munder 0.1%Trimmed-45,55321 May 2025 (the filing on sec.gov)
GAMCO Investors Inc99,323$6.1m0.07%Trimmed-5,26014 May 2025 (the filing on sec.gov)
Freestone Grove Partners LP13,816$843kunder 0.1%Trimmed-1,65215 May 2025 (the filing on sec.gov)
Harris Associates LP12,000$732kunder 0.1%Newnew15 May 2025 (the filing on sec.gov)

What managers have written about BMY

Shown because the letter names the company. A letter is commentary; it is not a record of why a position changed.

Every letter beside its positions →

Largest increases and reductions, by shares

Q4 2024 to Q1 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (3)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
31 in Q3 2024 to 22 in Q2 2026

Tracked managers listing it, at least.

02040602014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
BMY by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201322$12.2bnn.a.n.a.
Q3 201324$13.4bnn.a.n.a.
Q4 201323$14.8bnn.a.n.a.
Q1 201426$14.9bnn.a.n.a.
Q2 201425$14.7bnn.a.n.a.
Q3 201424$15.8bnn.a.n.a.
Q4 201421$18.3bnn.a.n.a.
Q1 201529$20.3bnn.a.n.a.
Q2 201524$21.7bnn.a.n.a.
Q3 201529$19.9bnn.a.n.a.
Q4 201529$22.5bnn.a.n.a.
Q1 201627$21.3bnn.a.n.a.
Q2 201631$24.0bnn.a.n.a.
Q3 201633$16.9bnn.a.n.a.
Q4 201633$20.1bnn.a.n.a.
Q1 201736$17.9bnn.a.n.a.
Q2 201736$17.8bnn.a.n.a.
Q3 201734$20.2bnn.a.n.a.
Q4 201735$19.0bnn.a.n.a.
Q1 201832$19.3bnn.a.n.a.
Q2 201833$18.0bnn.a.n.a.
Q3 201835$19.9bnn.a.n.a.
Q4 201836$16.6bnn.a.n.a.
Q1 201944$16.9bnn.a.n.a.
Q2 201931$16.8bnn.a.n.a.
Q3 201931$18.0bnn.a.n.a.
Q4 201929$24.1bnn.a.n.a.
Q1 202029$18.9bnn.a.n.a.
Q2 202035$18.0bnn.a.n.a.
Q3 202031$18.8bnn.a.n.a.
Q4 202028$16.4bnn.a.n.a.
Q1 202131$15.2bnn.a.n.a.
Q2 202127$16.3bnn.a.n.a.
Q3 202130$14.2bnn.a.n.a.
Q4 202128$12.9bnn.a.n.a.
Q1 202228$15.2bnn.a.n.a.
Q2 202231$14.8bnn.a.n.a.
Q3 202227$12.2bnn.a.n.a.
Q4 202233$10.0bnn.a.n.a.
Q1 202329$8.4bnn.a.n.a.
Q2 202329$7.9bnn.a.n.a.
Q3 202332$7.5bnn.a.n.a.
Q4 202330$7.2bn1912
Q1 202420$6.6bn1210
Q2 202426$6.4bn1710
Q3 202431$7.9bn1813
Q4 202427$6.6bn1413
Q1 202520$6.6bn913
Q2 202522$5.6bn168
Q3 202528$5.4bn199
Q4 202525$7.7bn1327
Q1 202627$8.3bn1722
Q2 202622$8.2bn1523

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

BMY and LLY →BMY and JNJ →BMY and VRTX →Choose a stock to compare with BMY →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own BMY, latest filings →Back to the 13F Explorer →